Transcriptome analyses provide a better understanding of how the genome is transformed into functional proteins. Their clinical benefit is that they permit expression profiles to be classified, which also constitutes a meaningful contribution to individualised medicine. We offer two powerful technologies for transcriptome analysis: hybridisation-based microarray technology and RNA sequencing.